Holen Sie sich die Stockscreener-App
65.82
1.69%
-1.13
Handel nachbörslich:
65.85
0.03
+0.05%
Schlusskurs vom Vortag:
$66.95
Offen:
$65.97
24-Stunden-Volumen:
1.09M
Relative Volume:
0.76
Marktkapitalisierung:
$8.98B
Einnahmen:
$550.17M
Nettoeinkommen (Verlust:
$201.35M
KGV:
65.82
EPS:
1
Netto-Cashflow:
$232.07M
1W Leistung:
-0.99%
1M Leistung:
-10.16%
6M Leistung:
+10.94%
1J Leistung:
+57.39%
1-Tages-Spanne:
$65.47
$67.10
1-Wochen-Bereich:
$65.22
$67.45
52-Wochen-Spanne:
$41.34
$85.21
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Vergleichen Sie DOCS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
65.82 | 12.54B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
293.49 | 47.98B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
84.49 | 15.41B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
95.03 | 8.17B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.49 | 7.08B | 906.14M | -52.62M | 89.62M | -0.3621 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Hussman Strategic Advisors Inc. Buys Shares of 52,500 Doximity, Inc. $DOCS - MarketBeat
Is Doximity Inc. stock overvalued by current metrics2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com
Can Doximity Inc. Class stock deliver strong annual returnsJuly 2025 Analyst Calls & Intraday High Probability Setup Alerts - newser.com
How risky is Doximity Inc. Class stock compared to peersTrade Entry Summary & High Conviction Buy Zone Picks - newser.com
Is Doximity Inc. stock a buy on dipsJuly 2025 Market Mood & Reliable Entry Point Alerts - newser.com
Live market analysis of Doximity Inc.Portfolio Risk Report & Weekly Chart Analysis and Trade Guides - newser.com
Backtesting results for Doximity Inc. trading strategies2025 Price Targets & Long Hold Capital Preservation Tips - newser.com
Real time social sentiment graph for Doximity Inc.Market Trend Summary & Community Verified Trade Signals - newser.com
Will Doximity Inc. stock recover faster than peersTreasury Yields & High Accuracy Trade Signal Alerts - newser.com
Doximity’s Digital Doctor Network Faces Slower Growth And Lofty Valuation - Finimize
Is Doximity Inc. stock attractive for hedge funds2025 Stock Rankings & Expert Curated Trade Ideas - newser.com
Will Doximity Inc. Class stock split increase liquidityBuy Signal & Free Daily Entry Point Trade Alerts - newser.com
Harel Insurance Investments & Financial Services Ltd. Makes New Investment in Doximity, Inc. $DOCS - MarketBeat
Will Doximity Inc. stock recover faster than marketShare Buyback & Consistent Income Trade Recommendations - newser.com
Why Doximity Inc. stock is a value investor pickBond Market & Real-Time Stock Movement Alerts - newser.com
Will a bounce in Doximity Inc. offer an exitDip Buying & High Accuracy Swing Entry Alerts - newser.com
Does Doximity Inc. qualify in momentum factor screeningJuly 2025 Big Picture & Smart Allocation Stock Tips - newser.com
Tick level data insight on Doximity Inc. volatilityJuly 2025 Fed Impact & Expert Approved Momentum Trade Ideas - newser.com
How to forecast Doximity Inc. trends using time seriesJuly 2025 Summary & Reliable Volume Spike Alerts - newser.com
Retirement Systems of Alabama Trims Stock Position in Doximity, Inc. $DOCS - MarketBeat
What Catalysts Could Shift the Narrative for Doximity Amid Analyst Debate? - Yahoo Finance
Is There Now An Opportunity In Doximity, Inc. (NYSE:DOCS)? - 富途牛牛
Why hedge funds are buying Doximity Inc. stock2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com
Will earnings trigger a reversal in Doximity Inc.2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
4.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):